Last reviewed · How we verify
Ferrous Sulfate tablets
At a glance
| Generic name | Ferrous Sulfate tablets |
|---|---|
| Also known as | Duroferon, Oral Iron Tablets, Oral Iron tablets |
| Sponsor | American Regent, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial (PHASE2)
- Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity (NA)
- Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study (PHASE3)
- EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA (NA)
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (PHASE4)
- Iron Absorption From Plant Heme Iron (NA)
- Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency (NA)
- Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ferrous Sulfate tablets CI brief — competitive landscape report
- Ferrous Sulfate tablets updates RSS · CI watch RSS
- American Regent, Inc. portfolio CI